Alderaan Biotechnology
PrivateLast Round
Series A
Jan 9, 2020
Total Funding Raised
$22.4M
Company Overview
Alderaan Biotechnology is a biotechnology company that develops monoclonal antibodies for the treatment of cancer by targeting regulatory T cells and modulating Natural Killer cell activity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alderaan Biotechnology Comparables
Compare Alderaan Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CheckmAb S.r.l. | 86% | |
| OREGA Biotech | 81% | |
| Black Belt Therapeutics Ltd. | 79% |
Alderaan Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 9, 2020 |
Alderaan Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Medicxi | Series A |
| AdBio partners | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2020
$21M round led by AdBio partners and Medicxi.
Alderaan Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alderaan Biotechnology's valuation, stock price, and market status.
Is Alderaan Biotechnology a public or private company?
Alderaan Biotechnology is a private company.
What is the current stock price of Alderaan Biotechnology?
Alderaan Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Alderaan Biotechnology worth (valuation)?
Valuation information for Alderaan Biotechnology is not publicly available.
Can I buy Alderaan Biotechnology stock?
Alderaan Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Alderaan Biotechnology's last funding round?
Alderaan Biotechnology's most recent funding round was Series A on January 9, 2020.
Who are the main investors in Alderaan Biotechnology?
Key investors in Alderaan Biotechnology include Medicxi, AdBio partners.
Will Alderaan Biotechnology IPO soon?
No public IPO plans have been announced for Alderaan Biotechnology.
How can I track Alderaan Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alderaan Biotechnology's secondary market activity and sign up for updates.